Tuesday, July 26, 2016

BRIEF-CytoDyn first patient enrolled in late-stage HIV study

* First patient enrolled under newly modified protocol in

cytodyn's phase 3 pro 140 combination study in HIV

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)